G Nigel Godson

Title: G Nigel Godson: Innovator in Malaria Vaccine Development

Introduction

G Nigel Godson is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of malaria research. He holds 2 patents that focus on innovative solutions for combating malaria, a disease that poses a serious threat to global health.

Latest Patents

His latest patents include a protective peptide antigen, which describes an antigen and antigenic amino acid sequence consisting of repeating units of the immunodominant epitope region of the circumsporozoite surface protein of a parasite of the genus Plasmodium. This invention also details a related fusion protein produced by a recombinant microorganism and a vaccine aimed at immunizing mammals against malaria. Another notable patent is the malaria vaccine, which provides antisera and monoclonal antibodies directed against the sporozoite stage of the malaria parasite. This invention is capable of offering protection against infection in both animals and humans. It further includes a purified antigen derived from sporozoites of the malaria parasite, suitable for use as a vaccine against malarial infections.

Career Highlights

G Nigel Godson is affiliated with New York University, where he continues to advance his research and innovations in the field of malaria. His work has the potential to significantly impact public health by providing new avenues for malaria prevention and treatment.

Collaborations

He has collaborated with notable colleagues, including Ruth S Nussenzweig and Victor N Nussenzweig, who share a commitment to advancing malaria research.

Conclusion

G Nigel Godson's innovative work in malaria vaccine development highlights his dedication to addressing critical health challenges. His contributions are paving the way for future advancements in the fight against malaria.